The Radiopharmaceutical Frontier: Navigating Manufacturing Bottlenecks with CDMOs
The Problem in Radiopharma – CDMOs? The field of radiopharmaceuticals is experiencing a remarkable renaissance, transitioning from primarily diagnostic tools to powerful therapeutic agents, particularly in oncology. This surge in innovation, driven by advancements in theranostics and targeted radionuclide therapies, is placing unprecedented demand on a highly specialized manufacturing ecosystem. Contract Development and Manufacturing Organizations […]